Article Topic
Plea Agreement, USA v Farace, October 2018
United States District Court District of Maryland USA v Ryan Farace Plea Agreement Filed October 3, 2018 Read the document.
[...]Judgment, USA v Farace, January 2024
United States District Court District of Maryland USA v Ryan and Joseph Farace Judgment Filed January 6, 2024 Read the document.
[...]Plea Agreement, USA v Farace, September 2022
United States District Court District of Maryland USA v Ryan and Joseph Farace Plea Agreement Filed September 8, 2022 Read the document.
[...]The Partnership for Safe Medicines supports S. 2943, the SHOP SAFE Act
On January 17, 2024 PSM wrote the Senate Subcommittee on Intellectual Property to endorse S.2934, which would expand the Trademark Act of 1946 to extend liability for selling harmful counterfeits to online platforms. Read the letter here.
[...]January 21, 2024: U.S. Adderall shortages continue to fuel a black market in fake pills
Tests of the counterfeits showed that they were made of many substances, including acetaminophen, duloxetine, caffeine and methamphetamine. Overseas, authorities seized counterfeit pregabalin in Belfast. Pakistan recalled toxic cough syrup. Fake Xanax trafficker Ryan Farace got an additional sentence for money laundering. News about pill presses in five states.
[...]NEW FOIA materials: Contracts with vendors for Florida’s and Colorado’s importation programs
PSM recently published contracts, some obtained via FOIA, with key vendors implementing Colorado’s and Florida’s Canadian drug importation plan. Read them here.
[...]Florida SIP application dated Oct 20, 2023 Attachment D
Attachment D Cover Letter Biktarvy Descovy Dovato Genoya Juluca Odefsey Prezcobix Prezista Ravicti Rexulti Symtuza Tivicay Vraylar Xtandi
[...]Partnership for Safe Medicines Condemns the Weakening of the U.S. Drug Supply through Canadian Drug Importation + Full coverage of decision
PSM’s statement on the FDA decision and full coverage including media stories, official documents, and statements from stakeholders.
[...]FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain
FDA continues to investigate counterfeit Ozempic (semaglutide) injection 1 milligram (mg) in the legitimate U.S. drug supply chain and has seized thousands of units of the product. FDA is aware of five adverse events from this lot.
[...]FDA Alert: Ginseng Compound Recalled for Containing Undeclared Drug Ingredients
This is a reprint of an FDA Alert. 8th Avenue Pharmacy Issues Voluntary Nationwide Recall of Notoginseng Formula Special Gout Granule Due to the Presence of Hidden Drug Ingredients, Diclofenac and Dexamethasone When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does…
[...]